Search

everythinglearnresearchcommunity

for

Search:↓

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Children with partial biotinidase deficiency are healthy at birth but may develop symptoms that improve with biotin therapy.

A mouse gene mutation increases the risk of skin cancer.

The Swedish neonatal screening program effectively detects PKU, galactosaemia, and biotinidase deficiency with low false positives.

mrp/plf-mRNA can indicate tumor-promoting effects in skin.

ErbB2 signaling is crucial for skin cell growth and cancer development in mice.

WNT10B is linked to cancer development and affects survival and disease progression in various cancers.

Recognizing rare tumor combinations is crucial for accurate diagnosis and treatment.

Genetic variations in hair keratin proteins exist but don't significantly affect hair structure.

Intralesional chemotherapy with 5-fluorouracil and methotrexate may worsen keratoacanthoma-type skin cancer in transplant patients.

Deleting Smad4 and PTEN genes in mice causes rapid, invasive stomach cancer.

Overexpressing GLI-1 in mice skin can cause tumors like human basal cell carcinomas.

Sun exposure and genetics increase skin cancer risk from precancerous lesions.

An 8-year-old Saudi boy was diagnosed with a rare genetic disorder causing hair loss, skin issues, and light sensitivity.

The SNP rs6457452 is linked to a higher risk of alopecia areata in Koreans.

CARASIL can cause different symptoms even with the same genetic mutation.

A genetic region near the PAX1 gene is linked to a higher risk of scoliosis in females.

Early diagnosis of pseudopelade of Brocq in men is crucial to prevent permanent hair loss.

A boy with a rare form of early puberty caused by a new gene mutation responded well to treatment aimed at reducing testosterone and preserving adult height.

Removing integrin α3β1 from hair stem cells lowers skin tumor growth by affecting CCN2 protein levels.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

A rare case of Cushing syndrome was successfully treated with one-sided adrenal gland removal, suggesting personalized treatment is important.

Researchers found a new mutation in the HR gene linked to a rare hair loss condition.

Overexpressing GLI-1 in mice skin can cause tumors like human basal cell carcinomas.

Acute leukemias with the Philadelphia chromosome may be biphenotypic, and identifying this is important for proper treatment.

Childhood and adult height, and early immune-related hospitalizations increase testicular cancer risk, while baldness, larger families, and sports reduce it.

A TP63 gene mutation causes significant hair loss and mild skin, nail, and tooth abnormalities.

A specific gene change in APCDD1 increases the risk of hair loss.

Albumin and prednisone improved symptoms in a woman with Cronkhite-Canada syndrome, revealing potential genetic causes.